Cargando…
A Late Presentation of COVID-19 Vaccine-Induced Myocarditis
With the introduction of the coronavirus disease 2019 (COVID-19) mRNA vaccines, the incidence of severe infection has significantly decreased. While the vaccines have been shown to be effective and safe, there have been few case reports of acute myocarditis within 3-5 days following the second dose...
Autores principales: | Gautam, Nitesh, Saluja, Prachi, Fudim, Marat, Jambhekar, Kedar, Pandey, Tarun, Al'Aref, Subhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504680/ https://www.ncbi.nlm.nih.gov/pubmed/34660088 http://dx.doi.org/10.7759/cureus.17890 |
Ejemplares similares
-
Coronary-Cameral Fistula, Thebesian Veins, and Anomalous Coronary Vein on Cardiac Computed Tomography
por: Xu, Jack, et al.
Publicado: (2021) -
Current and Future Applications of Artificial Intelligence in Coronary Artery Disease
por: Gautam, Nitesh, et al.
Publicado: (2022) -
Arrhythmogenic Cardiomyopathy as a Late Complication of COVID-19-Induced Myocarditis
por: Campoamor, David, et al.
Publicado: (2022) -
Variant Angina and Cannabis-Induced Myocarditis: A Rare Presentation of Myocardial Inflammation
por: Oudah, Bashar, et al.
Publicado: (2023) -
Machine Learning for Predicting Intubations in Heart Failure Patients: the Challenge of the Right Approach
por: Ghanta, Sai Nikhila, et al.
Publicado: (2023)